首页> 美国卫生研究院文献>World Journal of Gastroenterology >Transhepatic fibrinolysis of mesenteric and portal vein thrombosis in a patient with ulcerative colitis: A case report
【2h】

Transhepatic fibrinolysis of mesenteric and portal vein thrombosis in a patient with ulcerative colitis: A case report

机译:溃疡性结肠炎患者肠系膜和门静脉血栓形成的肝纤维蛋白溶解:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To present a case of acute mesenteric and portal vein thrombosis treated with thrombolytic therapy in a patient with ulcerative colitis in acute phase and to review the literature on thrombolytic therapy of mesenteric-portal system. Treatment of acute portal vein thrombosis has ranged from conservative treatment with thrombolysis and anticoagulation therapy to surgical treatment with thrombectomy and/or intestinal resection.METHODS: We treated our patient with intraportal infusion of plasminogen activator and then heparin through a percutaneous transhepatic catheter.RESULTS: Thrombus resolved despite premature interruption of the thrombolytic treatment for neurological complications, which subsequently resolved.CONCLUSION: Conservative management with plasminogen activator, could be considered as a good treatment for patients with acute porto-mesenteric thrombosis.
机译:目的:介绍溃疡性结肠炎患者急性期经溶栓治疗的急性肠系膜和门静脉血栓形成病例,并复习肠系膜-门静脉系统溶栓治疗的文献。急性门静脉血栓的治疗范围从溶栓治疗和抗凝治疗的保守治疗到血栓切除和/或肠切除的外科手术治疗。方法:我们先对患者进行了纤溶酶原激活剂的门内输注,然后通过经皮肝穿刺导管治疗肝素。尽管针对神经系统并发症的溶栓治疗过早中断,但血栓仍能解决。结论:纤溶酶原激活剂的保守治疗可被认为是急性门脉-肠系膜血栓形成的一种良好治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号